NZ306122A - Rage tumour rejection antigen precursors, diagnosis and treatment thereby - Google Patents

Rage tumour rejection antigen precursors, diagnosis and treatment thereby

Info

Publication number
NZ306122A
NZ306122A NZ306122A NZ30612296A NZ306122A NZ 306122 A NZ306122 A NZ 306122A NZ 306122 A NZ306122 A NZ 306122A NZ 30612296 A NZ30612296 A NZ 30612296A NZ 306122 A NZ306122 A NZ 306122A
Authority
NZ
New Zealand
Prior art keywords
rage
diagnosis
treatment
rejection antigen
antigen precursors
Prior art date
Application number
NZ306122A
Inventor
Beatrice Gaugler
Den Eynde Benoit Ven
Peter Schrier
Nathalie Brouwenstijn
Thierry Boon-Falleur
Original Assignee
Ludwig Inst Cancer Res
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/530,569 external-priority patent/US5939526A/en
Application filed by Ludwig Inst Cancer Res, Univ Leiden filed Critical Ludwig Inst Cancer Res
Publication of NZ306122A publication Critical patent/NZ306122A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ306122A 1995-03-21 1996-03-21 Rage tumour rejection antigen precursors, diagnosis and treatment thereby NZ306122A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40801595A 1995-03-21 1995-03-21
US08/530,569 US5939526A (en) 1995-03-21 1995-09-20 Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof
PCT/US1996/004037 WO1996029409A2 (en) 1995-03-21 1996-03-21 Rage tumor rejection antigens

Publications (1)

Publication Number Publication Date
NZ306122A true NZ306122A (en) 1999-06-29

Family

ID=27020105

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ306122A NZ306122A (en) 1995-03-21 1996-03-21 Rage tumour rejection antigen precursors, diagnosis and treatment thereby

Country Status (6)

Country Link
EP (1) EP0815229A2 (en)
JP (1) JPH11506904A (en)
AU (1) AU705768B2 (en)
CA (1) CA2211448A1 (en)
NZ (1) NZ306122A (en)
WO (1) WO1996029409A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050551A1 (en) * 1997-05-05 1998-11-12 Incyte Pharmaceuticals, Inc. Rage1-like protein
AU8571598A (en) * 1997-07-17 1999-02-10 Ludwig Institute For Cancer Research Cancer associated nucleic acids and polypeptides
AU3900399A (en) * 1998-05-13 1999-11-29 Ludwig Institute For Cancer Research Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
US6686147B1 (en) * 1998-07-15 2004-02-03 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
CN1367830A (en) * 1998-10-05 2002-09-04 路德维哥癌症研究院 Cancer associated antigens and uses therefor
WO2000020586A2 (en) * 1998-10-05 2000-04-13 Ludwig Institute For Cancer Research Renal cancer associated antigens and uses therefor
WO2006113540A2 (en) 2005-04-14 2006-10-26 Duke University Use of ntrosylated hemoglobin
US20110311448A1 (en) * 2007-11-02 2011-12-22 Ann Marie Schmidt Antibody to rage and uses for in vivo imaging or for targeting therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE280180T1 (en) * 1992-08-31 2004-11-15 Ludwig Inst Cancer Res ISOLATED NONAPEPTIDE DERIVED FROM MAGE-3 GENE AND PRESENTED BY HLA-A1 AND APPLICATIONS THEREOF

Also Published As

Publication number Publication date
AU705768B2 (en) 1999-06-03
EP0815229A2 (en) 1998-01-07
WO1996029409A3 (en) 1996-11-07
CA2211448A1 (en) 1996-09-26
JPH11506904A (en) 1999-06-22
WO1996029409A2 (en) 1996-09-26
AU5429896A (en) 1996-10-08

Similar Documents

Publication Publication Date Title
EP0668052A3 (en) Ultrasonic diagnosis and treatment system.
ZA9811029B (en) Tampon for feminine hygiene or medical purposes, and process for producing the same.
ZA973105B (en) Compounds and methods for the selective treatment of cancer and bacterial infections.
IL128850A0 (en) Medical treatment
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
EP0685219A3 (en) Hair treatment agent and process for its use.
ZA962280B (en) RAGE tumor rejection antigens
HU9802132D0 (en) Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use
AU2792789A (en) Method and means for selection of anti-idiotype antibodies and their use for the diagnosis, monitoring, treatment and/or prevention of cancer, autoimmune or infectious disease
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
NZ306122A (en) Rage tumour rejection antigen precursors, diagnosis and treatment thereby
GB9811598D0 (en) Diagnosis and treatment of cancer
ZA964198B (en) Treatment regime for skin.
GB9521725D0 (en) Medical treatment
GB9614578D0 (en) Medical treatment
ZA9610761B (en) Medical treatment.
ZA953237B (en) Medical treatment
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
IL124714A0 (en) Process for the diagnosis and treatment of squamous cell carcinomas
IL106658A0 (en) Cancer diagnosis and treatment
GB2307858B (en) Medical treatment
GB9716787D0 (en) Materials and methods for the diagnosis and treatment of breast cancer
GB9423702D0 (en) Diagnosis and treatment of tumours
AU5279996A (en) Antibodies and their use in cancer therapy and diagnosis